Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Undoubtedly, the most significant development in technology for the treatment of intracranial aneurysms since the release of the detachable coil has been flow diverting stents (FDS).1 The initial enthusiasm a decade ago was palpable; large and complex aneurysms with no good treatment option or having previously failed treatment were being safely cured by a simple endoluminal device implanted in a relatively short procedure.2 Early in the experience it was estimated that half of aneurysms could be treated with FDS technology.3
Funding The author has not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Commissioned; internally peer reviewed.